Sections
Rheumatology
Centers
Arthritis & Autoimmune Diseases Research Center
Biography
Dr. Jean Liew graduated from the University of Texas at Austin with degrees in Biology and English and went on to earn her MD at the University of Texas Medical Branch in Galveston, TX. She then relocated to the Pacific Northwest to complete an Internal Medicine residency at Oregon Health & Science University in Portland, OR followed by rheumatology fellowship at the University of Washington in Seattle, WA. She concurrently earned an M.S. in Epidemiology through the University of Washington School of Public Health. During her fellowship, the primary focus of her research was in axial spondyloarthritis (axSpA), specifically AS, and cardiovascular comorbidity.
She is currently an Assistant Professor of Medicine in the Section of Rheumatology at BU, where her clinical research currently focuses on knee osteoarthritis and axSpA. Additionally, as a member of the COVID-19 Global Rheumatology Alliance (GRA) and a member of its Steering Committee, she has led multiple projects relating to data collection, analysis, and dissemination of the impact of the COVID-19 pandemic on individuals with rheumatic disease.
Education
MD, University of Texas Medical Branch
Epidemiology, MS, University of Washington
English, BA, University of Texas at Austin
Biology, BS, University of Texas at Austin
Publications
Degirmenci HB, Peloquin CE, Westerland M, Lodi S, Machado PM, Jafarzadeh SR, Neogi T, Gensler LS, Dubreuil M, Liew JW. Trends in Opioid Prescriptions in Individuals with Axial Spondyloarthritis in the US and UK in the Last Two Decades: Analysis of Electronic Health Records and Insurance Claims Data. Arthritis Care Res (Hoboken). 2025 Sep 22. PMID: 40977482.
Published on 9/11/2025Achkar A, Peloquin C, Liew JW, Dubreuil M. Targeted and biologic therapies and risk of total knee or hip replacement in axial spondyloarthritis and psoriatic arthritis. Clin Rheumatol. 2025 Sep 11. PMID: 40936006.
Published on 9/5/2025George N, Liew JW, Wang N, Tilley S, Guermazi A, Lynch J, Lewis C, Torner J, Neogi T. Does hsCRP provide insights into an inflammatory phenotype of knee osteoarthritis? Osteoarthritis Cartilage. 2025 Sep 05. PMID: 40915380.
Published on 8/4/2025Wu Y, Liew JW, Boer JD, Westerland M, LaValley M, Voortman T, Bierma-Zeinstra S, Oei EHG, van Meurs JBJ, Neogi T, Boer CG. Chondrocalcinosis and incident knee osteoarthritis: findings from 2 large prospective cohorts with 20 years of follow-up. Ann Rheum Dis. 2025 Aug 04. PMID: 40764183.
Published on 8/1/2025Hmamouchi I, Liew JW, Ziade N, Abdullateef N, Abutiban F, Elrakawi M, Ghogho M, Graef ER, Hajjaj-Hassouni N, Masri B, Subki AH, Rolle NA, Halabi H, El Kibbi L. Engaging Arabic-Speaking Patients With Rheumatic Diseases Through Social Media: A Multinational Infodemiology Analysis. J Rheumatol. 2025 Aug 01. PMID: 40750316.
Published on 7/1/2025Ferrandiz-Espadin R, Liew JW. Spondyloarthritis Research and Treatment Network (SPARTAN) Clinical and Imaging Year in Review 2024. Curr Rheumatol Rep. 2025 Jul 01; 27(1):29. PMID: 40591037.
Published on 7/1/2025Jimenez DF, Thomason JL, Liew JW, Ferguson S, Hughes G, Bays AM. Delays in Tocilizumab Therapy for Patients With Giant Cell Arteritis in the United States. J Rheumatol. 2025 Jul 01; 52(7):699-703. PMID: 40089304.
Published on 6/1/2025Sendaydiego X, Gold LS, Dubreuil M, Andrews JS, Reid P, Liew DFL, Goulabchand R, Hughes GC, Sparks JA, Jarvik JG, Singh S, Liew JW, Singh N. Comparative safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs for cardiovascular outcomes in rheumatoid arthritis. Rheumatology (Oxford). 2025 Jun 01; 64(6):3434-3443. PMID: 39936579.
Published on 5/26/2025King LK, Mahmoudian A, Liew JW, Wang Q, Stanaitis I, Schiphof D, Callahan LF, Hunter DJ, Appleton CT, Turkiewicz A, Englund M, Lohmander LS, Haugen IK, Hawker GA, Neogi T, Runhaar J. Elucidating the initial symptoms and experiences of knee osteoarthritis: An international patient survey. Osteoarthritis Cartilage. 2025 Sep; 33(9):1147-1152. PMID: 40436245.
Published on 5/23/2025Hawker GA, King LK, Liew JW, Wang Q, Mahmoudian A, Jansen NEJ, Stanaitis I, Berenbaum F, Das S, Ding C, Emery CA, Filbay SR, Hochberg MC, Ishijima M, Kloppenburg M, Lane NE, Losina E, Mobasheri A, Runhaar J, Appleton CT, Turkiewicz A, Englund M, Lohmander LS, Haugen IK, Neogi T. OARSI initiative to develop classification criteria for early-stage symptomatic knee OA (EsSKOA): What conditions should be considered in the differential diagnosis of EsSKOA? Osteoarthritis Cartilage. 2025 Sep; 33(9):1141-1146. PMID: 40414550.
Media Mentions
Published on 8/14/2025
Calcium Deposition Can Increase Osteoarthritis Risk
Published on 5/3/2024
‘We are all busy’: Journal clubs offer data, connection for rheumatology experts, trainees
Published on 2/24/2023
It takes a village: Rheumatology trainees require multiple mentors, commitment
Published on 11/15/2022
Early TNF Inhibitor Initiation in Ankylosing Spondylitis Linked to Increase Cardiovascular Risk
Published on 11/11/2022
Early TNF Inhibitor Initiation in Ankylosing Spondylitis Linked to Increase Cardiovascular Risk
Published on 11/8/2022
Published on 4/12/2022
Jean Liew, MD, on Managing Axial Spondyloarthritis During High-Stress Times
Published on 2/14/2022
How to Find N95 Masks If You’re Immunocompromised
Published on 12/8/2021
Rheumatologists Navigate Treatment Plans in the Era of COVID-19 Vaccines
Published on 11/9/2021
Jean Liew, MD, MS, Discusses COVID-19 Vaccine Efficacy in Patients with Rheumatic Disease
View full list of 12 media mentions.